J Pediatr Genet 2021; 10(04): 311-314
DOI: 10.1055/s-0040-1713909
Case Report

Biallelic Mutation of SETX and Additional Likely “In Cis” SETX Sequence Change in Ataxia with Oculomotor Apraxia Type 2

Autoren

  • Michael D. Perry

    1   Department of Medical Education, St George’s Hospital Medical School, University of London, London, United Kingdom
  • Martin J. Evans

    1   Department of Medical Education, St George’s Hospital Medical School, University of London, London, United Kingdom
    2   Department of Postgraduate Medical Education, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
  • Philip J. Byrd

    3   Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom
  • Malcolm R. Taylor

    3   Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom

Abstract

Ataxia with oculomotor apraxia type 2 (AOA2) is a slowly progressive, autosomal recessive disease characterized by the triad of ataxia, oculomotor apraxia, and sensorimotor neuropathy. The genetic basis of AOA2 is biallelic mutation of the SETX gene, resulting in reduced or absent senataxin, a DNA/RNA repair protein essential for genomic stability.

In this case report, we described a case of AOA2 with two clear pathogenic SETX mutations, one of which is novel. We then discussed two further likely “in cis” SETX sequence changes (previously reported in the literature as pathogenic), and presented the case that they are likely benign polymorphisms.

Current Address of the Author: Royal United Hospital Bath NHS Foundation Trust, Department of Postgraduate Medical Education, Bath, United Kingdom.




Publikationsverlauf

Eingereicht: 30. April 2020

Angenommen: 27. Mai 2020

Artikel online veröffentlicht:
20. Juli 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany